Table 3 Comparison between the pooled prevalence in Arab countries with other regions around the world
Author (year) | Country | Sample size | BRCA mutation prevalence | z-score | P-value |
|---|---|---|---|---|---|
Keshavarzi et al. (2011) | Iran | 85 | 7% | 15.429 | <  0.0001 |
Vaca-Panigua et al. (2012) | Mexico | 39 | 7.7% | 13.97 | <  0.0001 |
Loman et al. (2001) | Sweden | 234 | 8.9% | 11.81 | <  0.0001 |
Hamann et al. (2003) | Germany | 23 | 13% | 6.30 | <  0.0001 |
Alsop et al. (2012) | Australia | 1001 | 14.1% | 5.134 | <  0.0001 |
Yazici et al. (2000) | Turkey | 53 | 15.1% | 4.144 | <  0.0001 |
Sharma et al., (2014) | Kansas, USA | 207 | 15.4% | 3.86 | 0.0001 |
Han et al. (2013) | Korea | 775 | 21.7% | 1.25 | 0.2117 |
Hedau et al. (2004) | India | 24 | 25% | 3.497 | = 0.0005 |
Sugano et al. (2008) | Japan | 135 | 26.7% | 4.59 | <  0.0001 |
Weitzel et al. (2005) | Hispanics in USA | 110 | 30.9% | 7.14 | <  0.0001 |
Hoya et al. (2001) | Spain | 102 | 43% | 14.07 | <  0.0001 |